{
     "PMID": "26811312",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20161213",
     "LR": "20161230",
     "IS": "1873-7862 (Electronic) 0924-977X (Linking)",
     "VI": "26",
     "IP": "3",
     "DP": "2016 Mar",
     "TI": "Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus.",
     "PG": "477-92",
     "LID": "10.1016/j.euroneuro.2015.12.040 [doi] S0924-977X(15)00430-7 [pii]",
     "AB": "In the reward mesocorticolimbic circuits, the glutamatergic and endocannabinoid systems are implicated in neurobiological mechanisms underlying cocaine addiction. However, the involvement of both systems in the hippocampus, a critical region to process relational information relevant for encoding drug-associated memories, in cocaine-related behaviors remains unknown. In the present work, we studied whether the hippocampal gene/protein expression of relevant glutamate signaling components, including glutamate-synthesizing enzymes and metabotropic and ionotropic receptors, and the hippocampal gene/protein expression of cannabinoid type 1 (CB1) receptor and endocannabinoid metabolic enzymes were altered following acute and/or repeated cocaine administration resulting in conditioned locomotion and locomotor sensitization. Results showed that acute cocaine administration induced an overall down-regulation of glutamate-related gene expression and, specifically, a low phosphorylation level of GluA1. In contrast, locomotor sensitization to cocaine produced an up-regulation of several glutamate receptor-related genes and, specifically, an increased protein expression of the GluN1 receptor subunit. Regarding the endocannabinoid system, acute and repeated cocaine administration were associated with an increased gene/protein expression of CB1 receptors and a decreased gene/protein expression of the endocannabinoid-synthesis enzymes N-acyl phosphatidylethanolamine D (NAPE-PLD) and diacylglycerol lipase alpha (DAGLalpha). These changes resulted in an overall decrease in endocannabinoid synthesis/degradation ratios, especially NAPE-PLD/fatty acid amide hydrolase and DAGLalpha/monoacylglycerol lipase, suggesting a reduced endocannabinoid production associated with a compensatory up-regulation of CB1 receptor. Overall, these findings suggest that repeated cocaine administration resulting in locomotor sensitization induces a down-regulation of the endocannabinoid signaling that could contribute to the specifically increased GluN1 expression observed in the hippocampus of cocaine-sensitized mice.",
     "CI": [
          "Copyright (c) 2016 Elsevier B.V. and ECNP. All rights reserved."
     ],
     "FAU": [
          "Blanco, Eduardo",
          "Galeano, Pablo",
          "Palomino, Ana",
          "Pavon, Francisco J",
          "Rivera, Patricia",
          "Serrano, Antonia",
          "Alen, Francisco",
          "Rubio, Leticia",
          "Vargas, Antonio",
          "Castilla-Ortega, Estela",
          "Decara, Juan",
          "Bilbao, Ainhoa",
          "de Fonseca, Fernando Rodriguez",
          "Suarez, Juan"
     ],
     "AU": [
          "Blanco E",
          "Galeano P",
          "Palomino A",
          "Pavon FJ",
          "Rivera P",
          "Serrano A",
          "Alen F",
          "Rubio L",
          "Vargas A",
          "Castilla-Ortega E",
          "Decara J",
          "Bilbao A",
          "de Fonseca FR",
          "Suarez J"
     ],
     "AD": "Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain; Departament de Pedagogia i Psicologia, Facultat dEducacio, Psicologia i Treball Social, Universitat de Lleida, Avda. de l'Estudi General 4, 25001, Lleida, Spain. Electronic address: eduardo.blanco@pip.udl.cat. Instituto de Investigaciones Bioquimicas de Buenos Aires (IIBBA-CONICET), Fundacion Instituto Leloir, Avda. Patricias Argentinas 435, C1405BWE Ciudad Autonoma de Buenos Aires, Argentina. Electronic address: pgaleano@leloir.org.ar. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: ana_parris@yahoo.es. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: javier.pavon@ibima.eu. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: riveragonzalez183@gmail.com. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: antonia.serrano@ibima.eu. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: p_alen@yahoo.es. Departamento de Anatomia y Medicina Legal, Universidad de Malaga, Campus de Teatinos s/n, 29071 Malaga, Spain. Electronic address: lorubio@uma.es. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: antoniovargasfuentes@gmail.com. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: estela.castilla@ibima.eu. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: juandecara@uma.es. Institute of Psychopharmacology, Central Institute of Mental Health, Faculty of Medicine Mannheim, University of Heidelberg, J5, 68159 Mannheim, Heidelberg, Germany. Electronic address: ainhoa.bilbao@zi-mannheim.de. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: fernando.rodriguez@ibima.eu. Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Avda. Carlos Haya 82, 29010, Malaga, Spain. Electronic address: juan.suarez@ibima.eu.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20160107",
     "PL": "Netherlands",
     "TA": "Eur Neuropsychopharmacol",
     "JT": "European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology",
     "JID": "9111390",
     "RN": [
          "0 (Dopamine Uptake Inhibitors)",
          "0 (Endocannabinoids)",
          "0 (RNA, Messenger)",
          "0 (Receptors, Glutamate)",
          "3KX376GY7L (Glutamic Acid)",
          "EC 3.5.- (Amidohydrolases)",
          "EC 3.5.1.- (fatty-acid amide hydrolase)",
          "I5Y540LHVR (Cocaine)"
     ],
     "SB": "IM",
     "MH": [
          "Amidohydrolases/genetics/metabolism",
          "Analysis of Variance",
          "Animals",
          "Cocaine/*pharmacology",
          "Dopamine Uptake Inhibitors/*pharmacology",
          "Endocannabinoids/genetics/*metabolism",
          "Gene Expression Regulation/*drug effects",
          "Glutamic Acid/metabolism",
          "Hippocampus/*drug effects/metabolism",
          "Locomotion/*drug effects",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "RNA, Messenger/metabolism",
          "Receptors, Glutamate/genetics/metabolism",
          "Signal Transduction/*drug effects/genetics",
          "Time Factors"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Cannabinoid",
          "Cocaine",
          "Cocaine sensitization",
          "Conditioned locomotion",
          "Glutamate",
          "Hippocampus"
     ],
     "EDAT": "2016/01/27 06:00",
     "MHDA": "2016/12/15 06:00",
     "CRDT": [
          "2016/01/27 06:00"
     ],
     "PHST": [
          "2015/08/23 00:00 [received]",
          "2015/12/15 00:00 [revised]",
          "2015/12/29 00:00 [accepted]",
          "2016/01/27 06:00 [entrez]",
          "2016/01/27 06:00 [pubmed]",
          "2016/12/15 06:00 [medline]"
     ],
     "AID": [
          "S0924-977X(15)00430-7 [pii]",
          "10.1016/j.euroneuro.2015.12.040 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur Neuropsychopharmacol. 2016 Mar;26(3):477-92. doi: 10.1016/j.euroneuro.2015.12.040. Epub 2016 Jan 7.",
     "term": "hippocampus"
}